Lilly (NYSE: LLY) makes drugs including Mounjaro for type 2 diabetes and Zepbound for obesity. For 2023, it reported $34 ...
Eli Lilly And Co. (NYSE:LLY) is a global pharmaceutical company that develops, manufactures, and markets prescription drugs for various therapeutic areas. It’s known for its innovative research ...
Its weight-loss drugs were removed from the FDA's shortage list during the quarter, while the company launched lower-cost single-use vials of Zepbound. As pharmaceutical giant Eli Lilly (LLY ...
INDIANAPOLIS, Oct. 28, 2024 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2024 of $1.30 per share on outstanding ...
Aktis, in a statement announcing the round, said all existing institutional investors also participated, as did strategic investors Bristol Myers Squibb (NYSE: BMY), Eli Lilly and Company (NYSE ...
Eli Lilly (NYSE:LLY) received approval from the Hong Kong government to launch its weight-loss drug—Mounjaro, with sales expected to begin as early as year-end, Bloomberg reported. The company ...
INDIANAPOLIS, Oct. 28, 2024 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2024 of $1.30 per share on outstanding common ...
Oct 27 (Reuters) - Eli Lilly (LLY.N), opens new tab expects to ... where rising medical costs in the third quarter caused the company to preannounce an earnings miss last month.
DePauw University students had a unique opportunity on Monday, Sept. 16, 2024, as the global pharmaceutical company Eli Lilly visited our campus. The event featured many activities, panels, and ...
Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Key drugs from Johnson & Johnson and Eli Lilly stand to ... senior vice president of Lilly’s immunology department, Mark Genovese, M.D., said in the company’s release. Ebyglyss picked up ...